Health & Fitness
Health and Fitness
Health and Fitness
Wed, May 12, 2010 St. Jude Medical to Showcase Arrhythmia Management Solutions at Heart Rhythm 2010
ST. PAUL, Minn.--([ BUSINESS WIRE ])--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it will display a number of new products and clinical solutions from the companya™s Cardiac Rhythm Management (CRM) and Atrial Fibrillation (AF) Divisions at Heart Rhythm 2010, the Heart Rhythm Societya™s 31st Annual Scientific Sessions. The new products highlight the companya™s commitment to providing the most comprehensive and technologically advanced portfolio of therapies and devices for the treatment of heart arrhythmias, including products that enhance connectivity.
"Advances in CRT and Heart Failure Treatment: From Guidelines to Clinical Care"
Commenting on the companya™s presence at Heart Rhythm 2010, Eric S. Fain, M.D., president of the St. Jude Medical Cardiac Rhythm Management Division, said, aThis year, we will have a strong focus on products that are helping to enhance connectivity, both between patients and their physician and for products within the cath lab. We will also feature a number of products that help eliminate the need for physicians to make compromises when selecting the most appropriate technology or therapy for treating their patients. In addition, the results of two of our clinical studies, the FREEDOM Trial and the ACT Registry, have been chosen to be presented during the late-breaking clinical trials sessions.a
Products and technologies will be on display at St. Jude Medical booth #1302 at the Colorado Convention Center in Denver, on Thursday, May 13 and Friday, May 14 from 9 a.m. to 5 p.m. and on Saturday, May 15 from 9 a.m. to noon. Product highlights include:
Cardiac Rhythm Management Division
- [ QuickFlexa" lead and CPS delivery tools: ] The QuickFlexa" (micro) left ventricular lead has an ultra-thin 4.3 French lead body, and short tip and ring electrodes (used to conduct energy), reducing the length of the lead's rigid portions. This, in addition to the leada™s steerable tip, helps to facilitate delivery through the acute bends that characterize the vessels in the left side of the heart, enabling physicians to better maneuver the lead to the optimal position for heart failure therapy. The CPS tools from St. Jude Medical, including the new [ CPSa" Aim SL slittable inner catheter subselector ], are designed to decrease implant times and increase control over LV access, delivery and fixation. The Quick Flex and CPS Aim SL inner catheter subselector are approved for use in the U.S. and Europe.
- [ Promotea" Accel ] and [ Currenta" Accel ]: The St. Jude Medical Accel family of ICD devices feature the AutoCapture® Pacing System, which ensures appropriate pacing thresholds are consistently maintained while potentially conserving battery life. This feature provides added safety for the patient and added efficiency for physicians, by automating vital threshold tests and providing results on demand via a simple device interrogation. The Accel device families also include a new AT/AF Alert feature, designed to notify physicians when a rapid atrial rate (atrial tachycardia/atrial fibrillation [AT/AF]) exceeds a programmed value or occurs over an extended time period. The devices can be programmed to notify the patient through a unique vibratory alert. Vibratory alerts have been proven more effective than audible alerts. The Promote Accel CRT-D and Current Accel ICD are approved for use in Europe and the U.S.
- Other CRM Division products on display: [ Accenta" RF pacemaker ], [ Anthema" RF CRT-P ], EHR Connectivity including Wireless USB Adaptor for [ Merlin@homea" transmitter ], [ Durataa" defibrillation leads ], [ SJ4 connector technology ], [ OptiSensea" 1999 leads ], the [ Optima" insulation ] lead family and the [ Merlina" Pacing System Analyzer (PSA) ].
Atrial Fibrillation Division
In addition to viewing the latest products on display, physicians can also get hands-on experience with several of the companya™s products by visiting the catheter ablation, Acrossa" Transseptal Access System, Agilisa" Steerable Introducer and EnSitea" Velocity stations at the St. Jude Medical booth.
- EnSite Derexia" module: The EnSite Derexi provides improved electrophysiology (EP) lab efficiency and workflow by enabling communication between the EnSite Velocity Cardiac Mapping System and the EP-Workmatea" Recording System. The EnSite Derexi module enables procedural data (including relevant images, waveforms and other clinical data) and patient medical history information to be shared between the mapping and recording system to produce a single, synchronized patient record of a procedure.
- Other AF Division products: [ Therapya" Cool Patha" Ablation Catheter ], [ EP-Workmate Recording System ], [ ViewMatea" II Intracardiac Ultrasound System ],[ Reflexiona"Spiral Circular Mapping Catheter, ][ Livewirea"Steerable DiagnosticCatheters ], [ Agilisa" NxT Steerable Introducer ], and [ Inquirya" Steerable DiagnosticCatheters ].
St. Jude Medical will also sponsor three continuing medical education (CME) symposia. "Improving Outcomes in Ischemia: The Value of Continuous ST-Segment Monitoring" and "Advances in CRT and Heart Failure Treatment: From Guidelines to Clinical Care" will both be presented on Wednesday, May 12, and "Innovative Therapy for the Management of Complex Arrhythmias" will be presented on Thursday, May 13.
For additional information about the products displayed in the St. Jude Medical booth, please visit [ sjm.com ].
About HRS
Heart Rhythm 2010 is the most comprehensive educational program for heart rhythm professionals, featuring more than 200 educational sections and more than 130 innovative products and services. The Heart Rhythm Societya™s Annual Scientific Sessions have become the must-attend event of the year, allowing the exchange of new vital ideas and information among colleagues from every corner of the globe. [ www.HRSonline.org ].
About St. Jude Medical
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. St. Jude Medical is headquartered in St. Paul, Minn., and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. For more information, please visit [ sjm.com ].
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon managementa™s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Companya™s control and the risk factors and other cautionary statements described in the Companya™s filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Companya™s Quarterly Report on Form 10-Q for the fiscal quarter ended April 3, 2010. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.
